Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 7, keine Gesamtzahl für „expected“
Suchtreffer
Begriffe & Kennungen
Kaletra · 4.5 · 60 No clinical relevant interaction fluvastatin or pravastatin is expected. recommended. Pravastatin is not me
Eintrag öffnenKaletra · 4.5 · 92 Inhaled, injectable or Fluticasone propionate, 50 g Greater effects may be expected intranasal fluticasone
Eintrag öffnenKaletra · 4.5 · Medicinal products that are contraindicated specifically due to the expected magnitude of interaction and pote
Eintrag öffnenKaletra · 4.5 · Medicinal products that are contraindicated specifically due to the expected magnitude of interaction and pote
Eintrag öffnenKaletra · 4.5 · Medicinal products that are contraindicated specifically due to the expected magnitude of interaction and pote
Eintrag öffnenKavigale · 4.5 · Sipavibart is not expected to be renally excreted or metabolised by cytochrome P450 enzymes (see section 5.2).
Eintrag öffnenKesimpta · 4.5 · No interaction studies have been performed, as no interactions are expected via cytochrome P450 enzymes, other
Eintrag öffnenKetoconazole Esteve (previously Ketoconazole HRA) · 4.5 · 10 Medicinal product by Expected effect on drug levels Recommendation for co- therapeutic area administration
Eintrag öffnenKetoconazole Esteve (previously Ketoconazole HRA) · 4.5 · 12 Medicinal product by Expected effect on drug levels Recommendation for co- therapeutic area administration
Eintrag öffnenKetoconazole Esteve (previously Ketoconazole HRA) · 4.5 · 13 Medicinal product by Expected effect on drug levels Recommendation for co- therapeutic area administration
Eintrag öffnenKetoconazole Esteve (previously Ketoconazole HRA) · 4.5 · 8 Medicinal product by Expected effect on drug levels Recommendation for co- therapeutic area administration D
Eintrag öffnenKetoconazole Esteve (previously Ketoconazole HRA) · 4.5 · 9 Medicinal product by Expected effect on drug levels Recommendation for co- therapeutic area administration T
Eintrag öffnenKetoconazole Esteve (previously Ketoconazole HRA) · 4.5 · Medicinal product by Expected effect on drug levels Recommendation for co- therapeutic area administration Ana
Eintrag öffnenKyprolis · 4.5 · Carfilzomib does not inhibit CYP1A2, 2B6, 2C8, 2C9, 2C19 and 2D6 in vitro and is therefore not expected to inf
Eintrag öffnenLeflunomide Zentiva (previously Leflunomide Winthrop) · 4.8 · Classification of expected frequencies:
Eintrag öffnenLeflunomide Zentiva (previously Leflunomide Winthrop) · 4.8 · Classification of expected frequencies:
Eintrag öffnenLeflunomide Zentiva (previously Leflunomide Winthrop) · 4.8 · Classification of expected frequencies:
Eintrag öffnenLeflunomide medac · 4.8 · Classification of expected frequencies: Very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000
Eintrag öffnenLeflunomide ratiopharm · 4.8 · Classification of expected frequencies:
Eintrag öffnenLocametz · 4.5 · Based on in vitro interaction studies, gallium (68Ga) gozetotide is not expected to have any clinically signif
Eintrag öffnen